Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_assertion type Assertion NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_head.
- NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_assertion description "[However, patients heterozygous for MTHFR A1298C or MTR A2756 G genotypes have 1.62- and 2.13-fold higher risk, respectively, of developing bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_provenance.
- NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_assertion evidence source_evidence_literature NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_provenance.
- NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_assertion SIO_000772 19837268 NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_provenance.
- NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_assertion wasDerivedFrom befree-20150227 NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_provenance.
- NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_assertion wasGeneratedBy ECO_0000203 NP577186.RAEkBuZCuWxpgfi-SCH8exJs4yX3b2qz4ARF3YH7ErcWg130_provenance.